(G)Patching up mis-splicing in cancer
Open Access
- 17 May 2024
- journal article
- editorial
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 49 (7) , 564-566
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignanciesMolecular Cell, 2024
- SON is an essential m6A target for hematopoietic stem cell fateCell Stem Cell, 2023
- DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancerProceedings of the National Academy of Sciences, 2022
- Synthetic introns enable splicing factor mutation-dependent targeting of cancer cellsNature Biotechnology, 2022
- RNA Splicing and CancerTrends in Cancer, 2020
- Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulationProceedings of the National Academy of Sciences, 2020
- Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1Molecular Cell, 2019
- Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associationsBlood, 2018
- Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15Science, 2017
- Tumor suppressor RBM5 directly interacts with the DExD/H‐box protein DHX15 and stimulates its helicase activityFEBS Letters, 2012